Initial cutaneous manifestations associated with histopathological leukocytoclastic vasculitis in two patients with antiphospholipid antibody syndrome

Journal of Dermatology

Volumn 32, Issue 12, 2005, Pages 1032-1037

  Kawakami, Tamihiro ^a   Soma, Yoshinao ^a   Mizoguchi, Masako ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antiphospholipid antibody syndrome; Cutaneous manifestation; Leukocytoclastic vasculitis; Widespread cutaneous necrosis

Indexed keywords

ACETYLSALICYLIC ACID; AUTOANTIBODY; AZATHIOPRINE; CARDIOLIPIN; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; PHOSPHOLIPID ANTIBODY; PREDNISOLONE;

ADULT; ANAMNESIS; ANTIPHOSPHOLIPID SYNDROME; ARTHRALGIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; JAPAN; LABORATORY TEST; LEUKOCYTOCLASTIC VASCULITIS; LIVEDO RETICULARIS; NECROTIZING ARTERITIS; PERIPHERAL NEUROPATHY; PURPURA; SKIN BIOPSY; SKIN MANIFESTATION; SKIN NECROSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

EID: 32944464260     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2005.tb00896.x     Document Type: Article

References (22)

1. Hughes GR: Thrombosis, abortion, cerebral disease, and the lupus anticoagulant, Br Med J, 287: 1088-1089, 1983.
2. Brighton TA, Hogg PJ, Dai YP, Murray BH, Chong BH, Chesterman CN: Beta 2-glycoprotein I in thrombosis: Evidence for a role as a natural anticoagulant, Br J Haematol, 93: 185-194, 1996.
3. Levy RA, Gharavi AE, Sammaritano LR, Habina L, Qamar T, Lockshin MD: Characteristics of IgG antiphospholipid antibodies in patients with systemic lupus erythematosus and syphilis, J Rheumatol, 17: 1036-1041, 1990.
4. Sammaritano LR, Gharavi AE, Lockshin MD: Antiphospholipid antibody syndrome: Immunologic and clinical aspects, Semin Arthritis Rheum, 20: 81-96, 1990.
5. Hunt JE, McNeil HP, Morgan GJ, Crameri RM, Krilis SA: A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection, Lupus, 1: 75-81, 1992.
6. Nahass GT: Acute radiodermatitis after radiofrequency catheter ablation, J Am Acad Dermatol, 36: 881-884, 1997.
7. Gibson GE, Su WP, Pittelkow MR: Antiphospholipid syndrome and the antiphospholipid antibody syndrome, J Am Acad Dermatol, 36: 970-982, 1997.
8. Wilson WA, Gharavi AE, Koike T, et al: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop, Arthritis Rheum, 42: 1309-1311, 1999.
9. Levine JS, Branch DW, Rauch J: The antiphospholipid syndrome, N Engl J Med, 346: 752-763, 2002.
10. DiFrancesco LM, Burkart P, Hoehn JG: A cutaneous manifestation of antiphospholipid antibody syndrome, Ann Plast Surg, 51: 517-522, 2003.
11. Creamer D, Hunt BJ, Black MM: Widespread cutaneous necrosis occurring in association with the antiphospholipid syndrome: A report of two cases, Br J Dermatol, 142: 1199-1203, 2000.
12. Asherson RA, Piette JC: The catastrophic antiphospholipid syndrome 1996: acute multi-organ failure associated with antiphospholipid antibodies: A review of 31 patients, Lupus, 5: 414-417, 1996.
13. Asherson RA, Mayou SC, Merry P, Black MM, Hughes GR: The spectrum of livedo reticularis and anticardiolipin antibodies, Br J Dermatol, 120: 215-221, 1989.
14. Goldberger E, Elder RC, Schwartz RA, Phillips PE: Vasculitis in the antiphospholipid syndrome. A cause of ischemia responding to corticosteroids, Arthritis Rheum, 35: 569-572, 1992.
15. Belmont HM, Abramson SB, Lie JT: Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium, Arthritis Rheum, 39: 9-22, 1996.
16. Del Papa N, Raschi E, Catelli L, et al: Endothelial cells as a target for antiphospholipid antibodies: role of anti-beta 2 glycoprotein I antibodies, Am J Reprod Immunol, 38: 212-217, 1997.
17. Smith KJ, Skelton HG, James WD, et al: Cutaneous histopathologic findings in 'antiphospholipid syndrome'. Correlation with disease, including human immunodeficiency virus disease, Arch Dermatol, 126: 1176-1183, 1990.
18. Pierangeli SS, Colden-Stanfield M, Liu X, Barker JH, Anderson GL, Harris EN: Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo, Circulation, 99: 1997-2002, 1999.
19. Cervera R, Khamashta MA, Font J, et al: Antiendothelial cell antibodies in patients with the antiphospholipid syndrome, Autoimmunity, 11: 1-6, 1991.
20. Escolar G, Font J, Reverter JC, et al: Plasma from systemic lupus erythematosus patients with antiphospholipid antibodies promotes platelet aggregation. Studies in a perfusion system, Arterioscler Thromb, 12: 196-200, 1992.
21. Freyssinet JM, Cazenave JP: Lupus-like anticoagulants, modulation of the protein C pathway and thrombosis, Thromb Haemost, 58: 679-681, 1987.
22. Alarcon-Segovia D, Perez-Vazquez ME, Villa AR, Drenkard C, Cabiedes J: Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus, Semin Arthritis Rheum, 21: 275-286, 1992.